TIRRI, Rosella
 Distribuzione geografica
Continente #
EU - Europa 13.309
NA - Nord America 2.578
AS - Asia 2.188
SA - Sud America 348
AF - Africa 33
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 1
Totale 18.465
Nazione #
IT - Italia 7.757
RU - Federazione Russa 3.123
US - Stati Uniti d'America 2.536
SG - Singapore 762
IE - Irlanda 559
CN - Cina 458
UA - Ucraina 392
FR - Francia 322
BR - Brasile 297
GB - Regno Unito 292
VN - Vietnam 270
HK - Hong Kong 266
NL - Olanda 255
DE - Germania 187
KR - Corea 169
FI - Finlandia 122
TR - Turchia 98
SE - Svezia 73
GR - Grecia 67
IN - India 55
JP - Giappone 43
ES - Italia 35
CH - Svizzera 26
PL - Polonia 24
CA - Canada 21
BE - Belgio 20
AR - Argentina 19
AT - Austria 15
EC - Ecuador 12
BD - Bangladesh 11
ID - Indonesia 11
ZA - Sudafrica 10
MX - Messico 9
RO - Romania 9
UZ - Uzbekistan 7
CO - Colombia 6
HR - Croazia 6
IQ - Iraq 6
KE - Kenya 6
PK - Pakistan 6
TW - Taiwan 6
EG - Egitto 5
EU - Europa 5
LT - Lituania 5
MA - Marocco 5
RS - Serbia 5
VE - Venezuela 5
PE - Perù 4
DO - Repubblica Dominicana 3
HU - Ungheria 3
JO - Giordania 3
KZ - Kazakistan 3
AL - Albania 2
AP - ???statistics.table.value.countryCode.AP??? 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
GT - Guatemala 2
IL - Israele 2
IR - Iran 2
JM - Giamaica 2
NO - Norvegia 2
PH - Filippine 2
PR - Porto Rico 2
PY - Paraguay 2
SA - Arabia Saudita 2
TN - Tunisia 2
UY - Uruguay 2
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CL - Cile 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
KG - Kirghizistan 1
LB - Libano 1
MK - Macedonia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
SM - San Marino 1
SN - Senegal 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 18.465
Città #
Moscow 1.141
Dublin 552
Rome 525
Jacksonville 463
Milan 432
Singapore 379
Santa Clara 350
Hong Kong 263
Chandler 253
Naples 191
Seoul 169
San Jose 151
Palermo 95
Florence 94
Turin 88
Princeton 85
Ashburn 84
Ann Arbor 81
Ho Chi Minh City 75
Hanoi 72
Catania 67
Medford 63
Bologna 62
Nanjing 62
Bari 61
Roxbury 54
Beijing 53
Hefei 53
Boardman 50
Padova 49
San Mateo 43
Dallas 41
Helsinki 41
Napoli 41
Woodbridge 41
Verona 39
The Dalles 38
Caserta 37
Wilmington 37
Genoa 34
Cambridge 33
Bengaluru 28
Cagliari 25
Taranto 25
Torino 25
Brescia 24
Messina 24
Vicenza 24
Pescara 23
Venice 23
Da Nang 22
Livorno 20
Parma 20
Des Moines 19
Modena 19
Como 18
Genova 18
Los Angeles 18
Perugia 18
Trieste 18
Düsseldorf 16
Reggio Emilia 16
São Paulo 16
Trento 16
Brussels 15
Gorno 15
New York 15
Reggio Calabria 14
Salerno 14
Kunming 13
Nanchang 13
Redwood City 13
Belluno 11
Bergamo 11
Bolzano 11
Bremen 11
Mountain View 11
Nuremberg 11
Orem 11
Rimini 11
Terni 11
Varese 11
Catanzaro 10
Haiphong 10
Hanover 10
Mykolayiv 10
Prato 10
Bastia umbra 9
Cosenza 9
Guangzhou 9
Houston 9
Lecce 9
Lucca 9
Marano Di Napoli 9
Sassari 9
Shanghai 9
Assisi 8
Auburn Hills 8
Carbonera 8
Latina 8
Totale 7.402
Nome #
ARTRITE PSORIASICA ED INTERSTIZIOPATIA POLMONARE : DESCRIZIONE DI UN CASO CLINICO. 8.338
ANTI TNF ALFA IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE E SPONDILOARTRITI HBV CARRIERS OCCULTI:STUDIO RETROSPETTIVO SULLA SICUREZZA 301
RAPPORTO TRA QUALITÀ DEL SONNO E DOLORE CRONICO IN PAZIENTI CHE ACCEDONO PER LA PRIMA VOLTA AD UN AMBULATORIO SPECIALISTICO DI REUMATOLOGIA R. Ferrara, D. Capocotta, R. Tirri 264
CROSSLINKS PIRIDINICI URINARI IN PAZIENTI AFFETTI DA SCLEROSI SISTEMICA 190
Antinuclear antibodies in first-degree relatives of patients with polymyositis-dermatomyositis: analysis of the relationship with HLA haplotypes 186
ANTI-TNFα TREATMENT IS ASSOCIATED WITH INCREASED LIVER STIFFNESS IN HBV OCCULT CARRIER PATIENTS 180
ESCREZIONE URINARIA DI PIRIDINOLINE IN PAZIENTI DI SCLEROSI SISTEMICA E LUPUS ERITEMATOSO SISTEMICO 170
MANIFESTAZIONI OCULARI NELLA POLI-DERMATOMIOSITE 169
Evidence for bone resorption in systemic sclerosis 165
CROSSLINKS DEL COLLAGENE NELLE URINE DI PAZIENTI SCLERODERMICI: RISULTATI PRELIMINARI 158
INCREASED LEVES OF URINARY PYRIDINIUM CROSSLINKS OF COLLAGEN IN SYSTEMIC SCLEROSIS. 154
[The nephrotic syndrome and pheochromocytoma. A report of a rare clinical case] 151
. ERYTHEMA YRATUM REPENS AND RHEUMATOID ARTHRITIS:CONNECTED FOR THE FIRST TIMe 149
TERAPIA DEL LUPUS ERITEMATOSO SISTEMICO CON MEGADOSI DI METILPREDNISOLONE. RISULTATI ED EFFETTI COLLATERALI IN 14 PAZIENTI. 146
Rosacea and abatacept: the first report of a possible correlation 146
.ANTI-TNF alfa IN PATIENTS WITH EITHER RHEUMATOID ARTHRITIS OR SPONYLOATHRITIS And CONCURRENT C HEPATITIS:A RETROSPECTIVE RECORD REVIEW ON SAFETY 143
ARTHRITIS IS ASSOCIATED WITH PSORIASIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES 143
30. SULLA EFFICACIA E TOLLERABILITA DELLACQUA MEDIO-MINERALE FONTE LILIA IN PAZIENTI DISPEPTICI ED IPERURICEMICI. 142
ASSOCIAZIONE CIRROSI BILIARE PRIMITIVA (CBP)/SCLEROSI SISTEMICA SINE SCLERODERMIA (Ssss). 137
Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE) 136
[Cardiac changes in dermatomyositis] 134
PREVALENCE OF ANTIBODIES RECOGNAIZING CYCLIC CITRULLINATED PEPTIDE(anti CCP) IN PATIENTS WITH ULCERATIVE COLITIS 133
Absence of elevated creatine kinase in dermatomyositis does not exclude malignancy 133
ANTINUCLEAR ANTIBODIES IN PROGRESSIVE SYSTEMIC SCLEROSIS: FANA AND ANTIBODIES TO ENA. 131
[The effect of water with medium mineral content on various biohumoral parameters of uric acid metabolism] 127
ANTI-TOPOISOMERASE I (ANTI-SCL-70) AND CANCER IN SYSTEMIC SCLEROSIS. ARE THEY RELATED? 127
Cardiac involvement in rheumatoid arthritis: an echocardiographic study 126
ANTICORPI ANTICARDIOLIPINA ED ABORTO ABITUALE IN ASSENZA DI ALTRE CAUSE FAVORENTI 125
Evidence for peripheral impaired glucose handling in patients with connective tissue diseases 124
Analisi delle modalità di afferenza e delle caratteristiche cliniche di pazienti con Fenomeno di Raynaud al primo accesso in un ambulatorio specialistico di reumatologia. 123
RELAPSING POLYCHONDRITIS. AN HYSTOCHEMICAL STUDY BY LECTIN. 121
METHYPREDNISOLONE PULSE THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS (A STUDY OF 11 CASES 121
Erythema gyratum repens and rheumatoid arthritis: an unrecognized association? 120
Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus 119
[Clinico-developmental aspects in 44 cases of polymyositis/dermatomyositis] 119
[Electromyographic studies in patients with progressive systemic sclerosis] 118
ASPETTI CLINICO-EVOLUTIVI IN 44 CASI DI POLIMIOSITE/ DERMATOMIOSITE 117
Tocilizumab in the treatment of patients with rheumatoid arthritis in real clinical practice: Results of an Italian observational study 114
Methylprednisolone pulse therapy as primary management strategy in systemic lupus erythematosus. 109
Aspetti recenti del termalismo in Campania 108
Succesfull neridronate therapy in transient osteoporosis of the hip 108
CEREBRAL ATROPHY IN SLE PATIENTS: A CONSEQUENCES OF STEROID TREATMENT ? 107
Adult onset Still s Disease:a rare paraneoplastic Syndrome? 107
IMPIEGO DELLA FANGOBALNEOTERAPIA ALLA LUCE DELLE RECENTI ACQUISIZIONI SULLA CLINICA DELLE MALATTIE REUMATICHE 105
False positivity of prenatal Down's syndrome and neural-tube tests in SLE 103
Cerebral atrophy in SLE patients: a consequence of steroid treatment? 103
INCIDENZA DI REAZIONI AVVERSE IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE IN TERAPIA CON UN PRIMO E/O UN SECONDO ANTI TNF ALFA 102
CK MB ED ISOENZIMI 1 E 2 DELLA LAD NELLA PM/DM. 101
MANIFESTAZIONI OCULARI IN GIOVANI ED ADULTI AFFETTI DA MALATTIE REUMATICHE 101
Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient 99
Mediterranean Symposium of rheumatology 98
COGANS SYNDROME: A CASE REPORT. 98
Incidence of microalbuminuria in obese hypertensive subjects 98
SUL COMPORTAMENTO DELLA DENSITA MINERALE RADIALE NEGLI OBESI. 98
VALUTAZIONI ECOCARDIOGRAFICHE NEI SOGGETTI OBESI. 98
Leflunomide in psoriatic arthritis: a retrospective study of discontinuation rate in daily clinical practice compared with methotrexate. 96
EFFICACIA TERAPEUTICA DI UNA NUOVA ACQUA OLIGOMINERALE (SORGENTE FONTEVERDE) IN PAZIENTI GOTTOSI. 96
LONG TERM SAFETY OF ANTI -TNF ALFA IN PATIENTS WITH INFLAMMATORY ARTHRITIS AND HBV INFECTION: FOCUS ON HEPATITIS B SURFACE ANTIBODY STATUS 95
POLYMYOSITIS ASSOCIATED WITH OTHER CONNECTIVES TISSUE DISEASES: NEUROPHYSIOLOGICAL STUDY OF 7 CASES 94
GOTTA: EVOLUZIONE NON CONTROLLATA NELL’ERA DELL’APPROCCIO “TREAT TO TARGET SERUM URATE” 94
safety of methotrexate in rheumatoid arthritis: a retrospective cohort study in clinical practice 93
VALUTAZIONI CLINICO-NEUROFISIOLOGICHE IN PAZIENTI CON SCLEROSI SISTEMICA PROGRESSIVA 93
The relationship among pain sleep disorders and smoke in patients who assess for the first time in a Rheumatology Unit 93
Foot involvement in systemic sclerosis: a longitudinal study of 100 patients 92
DRUG SURVIVAL OF THE FIRST COURSE OF ANTI-TNF AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SERONEGATIVE SPONDYLOARTHRITIS: ANALYSIS FROM THE MONITORNET DATABASE. 92
EFFECTS OF A REHABILITATION PROGRAM IN FIBROMYALGIA PATIENTS IN PHARMACOLOGICAL TREATMENT 92
QUALITY OF LIFE AND UNMET NEEDS IN PATIENTS WITH INFLAMMATORY ARTHROPATHIES RESULTS FROM THE MULTICENTER, OBSERVATIONAL RAPSODIA STUDY. 90
POLYMYOSITIS ASSOCIATED WITH OTHER CONNECTIVE TISSUE DISEASES: NEUROPHYSIOLOGICAL STUDY OF 7 CASES 90
UTILITA DELLA TOMOGRAFIA ASSIALE COMPUTERIZZATA CRANIO-CEREBRALE NEL LUPUS ERITEMATOSO SISTEMICO. 90
POLYMYOSITIS ASSOCIATED WITH OTHER CONNECTIVE TISSUE DISEASES: NEUROPHYSIOLOGICAL STUDY OF 7 CASES. 89
Sclerosi sistemica 89
RS3PE e Diabete Mellito di tipo 2: utilità diagnostica dell’Ultrasonografia 89
Evaluation of microalbuminuria in obese subjects with preserved renal function 88
Clinical pattern of pain in rheumatoid arthritis 88
EPIDEMIOLOGIA E PREVENZIONE DELLE MALATTIE REUMATICHE 87
IPERSONNOLENZA IN PAZIENTI CON MALATTIE REUMATICHE COMUNEMENTE ASSOCIATE A DOLORE D. Capocotta, R. Ferrara, R. Tirri 87
RELEVANCE OF ELECTROPHYSIOLOGICAL INVESTIGATIONS IN SISTEMIC SCLEROSIS 86
L’IMPEGNO MUSCOLARE NELLA FASCITE EOSINOFILA: STUDIO ELETTROFISIOLOGICO IN 2 CASI. 85
SLEEP DISORDERS IN PATIENTS AT THE FIRST ACCESS TO A RHEUMATHOLOGY OUTPATIENT Clinic 85
Pott's disease of the lower cervical spine in a diabetic patient 84
TNF alfa inhibitors and tocilizumab do not influence hepatic steatosis in patients with Rheumatoid arthritis 83
DRUG SURVIVAL OF THE FIRST COURSE OF ANTI-TNF AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SPONDYLOARTHROPATHIES. RESULTS FROM THE MONITORNET DATABASE 81
The data project: a shared approach between stakeholders of the healthcare system in definition of a therapeutic algorithm for inflammatory arthritis 80
The predictive value of attributes of pain to classify rheumatoid arthritis 80
OCULAR INVOLVEMENT IN POLYMYOSITYS/DERMATOMYOSITIS 79
Un raro caso di artrite post infettiva associata ad ascaridiasi 75
The contribute of sleep quality and mood disturbances on pain perception in patients with rheumatic diseases at first access 72
The measurement of fibromyalgia severity: converting scores between the FIQR, the PSD and the FASmod 69
Incidental papillary thyroid cancer diagnosis in patientwith adult onset Still disease-like manifestations 68
Multifocal fibrosclerosis in a patient with HIV infection treated with rituximab 64
Determining the PASS cut-off points for the FIQR, FASmod and PSD in patients with fibromyalgia: a registry-based study 62
null 45
Multifocal fibrosclerosis in a patient with HIV infection treated with rituximab 8
Totale 18.666
Categoria #
all - tutte 41.271
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.271


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021461 0 0 0 0 0 0 0 0 0 188 161 112
2021/20221.535 118 65 85 85 272 92 92 141 87 151 116 231
2022/20232.283 184 88 85 149 170 168 108 198 626 164 170 173
2023/20241.960 126 94 155 190 292 83 177 213 128 146 188 168
2024/20252.775 122 174 119 183 365 312 285 238 355 251 232 139
2025/20265.800 289 317 304 329 524 3.021 315 319 307 75 0 0
Totale 18.666